Status:
UNKNOWN
Lab-on-a-chip Detection of Cervical Cancer Tumour Markers
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Collaborating Sponsors:
Imperial College London
St. George's NHS Foundation Trust
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
This study aims to establish whether tumour markers measured from cytological samples can improve cervical cancer detection both prior to treatment and after treatment during follow up. All patients ...
Detailed Description
Cervical cytology: This will be done prior to MRI at an out-patient visit or at the scan visit in all study subjects with cancer. IN those patients with a normal cervix at colposcopy, the sample will ...
Eligibility Criteria
Inclusion
- • Patients with presumed early stage cervical cancer (squamous or adenocarcinoma on histology) being considered for curative surgery.
- Patients treated surgically for cervical cancer (squamous or adenocarcinoma on histology) being followed-up for suspected recurrent disease.
- Patients with normal cervix at colposcopy examination.
Exclusion
- Ferromagnetic metal implants, claustrophobia (MRI incompatibility). Neuroendocrine or unusual histological subtypes. Abnormal cervix seen at colposcopy examination (for Normal cervix cohort).
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03380741
Start Date
April 1 2018
End Date
September 1 2019
Last Update
December 21 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.